wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38930362-0C00128D-0CFE-4FEF-9F14-D443D2A220F3
Q38930362-0C00128D-0CFE-4FEF-9F14-D443D2A220F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38930362-0C00128D-0CFE-4FEF-9F14-D443D2A220F3
Targeted Therapies for Lung Cancer.
P2860
Q38930362-0C00128D-0CFE-4FEF-9F14-D443D2A220F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38930362-0C00128D-0CFE-4FEF-9F14-D443D2A220F3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f1835d725a4202497bec0d17213c4ebef0d0312b
P2860
Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)